Misplaced Pages

#638361

24-650: The National Comprehensive Cancer Network ( NCCN ) is an alliance of 33 cancer centers in the United States, most of which are designated by the National Cancer Institute (one of the U.S. National Institutes of Health ) as comprehensive cancer centers . It is a non-profit organization with offices in Plymouth Meeting, Pennsylvania. John W. Sweetenham, MD, FRCP, FACP, FASCO, from UT Southwestern Simmons Comprehensive Cancer Center,

48-505: A change in the refractive index of the cell, cytoplasmic shrinkage, nuclear condensation and cleavage of DNA into regularly sized fragments. Cells in culture that are undergoing apoptosis eventually undergo secondary necrosis. They will shut down metabolism, lose membrane integrity and lyse. Cytotoxicity assays are widely used by the pharmaceutical industry to screen for cytotoxicity in compound libraries. Researchers can either look for cytotoxic compounds, if they are interested in developing

72-425: A colour change by interaction with a specific probe. Protease biomarkers have been identified that allow researchers to measure relative numbers of live and dead cells within the same cell population. The live-cell protease is only active in cells that have a healthy cell membrane, and loses activity once the cell is compromised and the protease is exposed to the external environment. The dead-cell protease cannot cross

96-454: A genetic program of controlled cell death ( apoptosis ). Cells undergoing necrosis typically exhibit rapid swelling, lose membrane integrity, shut down metabolism, and release their contents into the environment. Cells that undergo rapid necrosis in vitro do not have sufficient time or energy to activate apoptotic machinery and will not express apoptotic markers. Apoptosis is characterized by well defined cytological and molecular events including

120-515: A kit format. A label-free approach to follow the cytotoxic response of adherent animal cells in real-time is based on electric impedance measurements when the cells are grown on gold-film electrodes. This technology is referred to as electric cell-substrate impedance sensing (ECIS). Label-free real-time techniques provide the kinetics of the cytotoxic response rather than just a snapshot like many colorimetric endpoint assays. Material that has been determined as cytotoxic, typically biomedical waste ,

144-749: A nationwide network of 72 NCI-designated Cancer Centers with a dedicated focus on cancer research and treatment and maintains the National Clinical Trials Network. Antimetabolites Plant flavonoids Hormones and steroids Biologicals The NCI is divided into several divisions and centers. The NCI-designated Cancer Centers are one of the primary arms in the NCI's mission in supporting cancer research. There are currently 72 so-designated centers; 9 cancer centers, 56 comprehensive cancer centers, and 7 basic laboratory cancer centers. NCI supports these centers with grant funding in

168-509: A therapeutic that targets rapidly dividing cancer cells, for instance; or they can screen "hits" from initial high-throughput drug screens for unwanted cytotoxic effects before investing in their development as a pharmaceutical. Assessing cell membrane integrity is one of the most common ways to measure cell viability and cytotoxic effects. Compounds that have cytotoxic effects often compromise cell membrane integrity. Vital dyes, such as trypan blue or propidium iodide are normally excluded from

192-445: Is any unique response of the drug which is not similar to any of the standard prototype compounds in the NCI database. Cytotoxicity Cytotoxicity is the quality of being toxic to cells . Examples of toxic agents are toxic metals, toxic chemicals, microbe neurotoxins, radiation particles and even specific neurotransmitters when the system is out of balance. Also some types of drugs, e.g alcohol , and some venom , e.g. from

216-708: Is chairman of the NCCN Board of Directors. It publishes a peer-reviewed medical journal called Journal of the National Comprehensive Cancer Network . The NCCN was publicly announced in 1995. The first edition of the Journal of the National Comprehensive Cancer Network was published in 2003. Experts from the 33 NCCN Member Institutions are recognized for dealing with complex, aggressive, or rare cancers. The 33 NCCN Member Institutions are: National Cancer Institute NCI

240-433: Is interfering with the cell division. These drugs cannot distinguish between normal and malignant cells, but they inhibit the overall process of cell division with the purpose to kill the cancers before the hosts. Antibody-dependent cell-mediated cytotoxicity (ADCC) describes the cell-killing ability of certain lymphocytes , which requires the target cell being marked by an antibody . Lymphocyte-mediated cytotoxicity, on

264-486: Is often marked with a symbol that consists of a capital letter "C" inside a triangle. A highly important topic is the prediction of cytotoxicity of chemical compounds based on previous measurements, i.e. in-silico testing. For this purpose many QSAR and virtual screening methods have been suggested. An independent comparison of these methods has been done within the "Toxicology in the 21st century" project. Some chemotherapies contain cytotoxic drugs, whose purpose

SECTION 10

#1732780309639

288-408: Is the limiting reagent for the luciferase reaction. Cytotoxicity can also be measured by the sulforhodamine B (SRB) assay, WST assay and clonogenic assay . Suitable assays can be combined and performed sequentially on the same cells in order to reduce assay-specific false positive or false negative results. A possible combination is LDH-XTT-NR (Neutral red assay)-SRB which is also available in

312-860: Is the oldest and has the largest budget and research program of the 27 institutes and centers of the NIH ($ 6.9 billion in 2020). It fulfills the majority of its mission via an extramural program that provides grants for cancer research. Additionally, the National Cancer Institute has intramural research programs in Bethesda, Maryland , and at the Frederick National Laboratory for Cancer Research at Fort Detrick in Frederick, Maryland . The NCI receives more than US$ 5 billion in funding each year. The NCI supports

336-508: The 60 cell line assay . Those passing certain thresholds are subjected to a 5 dose screen of the same 60 cell-line panel to determine a more detailed picture of the biological activity. A second phase screen establishes the maximum tolerable dosage and involves in vivo examination of tumor regression using the hollow fiber assay. The third phase of the study is the human tumor xenograft evaluation. Active compounds are selected for testing based on several criteria: disease type specificity in

360-411: The in vitro assay, unique structure, potency, and demonstration of a unique pattern of cellular cytotoxicity or cytostasis, indicating a unique mechanism of action or intracellular target. A high correlation of cytotoxicity with compounds of known biological mechanism is often predictive of the drugs mechanism of action and thus a tool to aid in the drug development and testing. It also tells if there

384-411: The puff adder ( Bitis arietans ) or brown recluse spider ( Loxosceles reclusa ) are toxic to cells. Treating cells with the cytotoxic compound can result in a variety of prognoses. The cells may undergo necrosis , in which they lose membrane integrity and die rapidly as a result of cell lysis . The cells can stop actively growing and dividing (a decrease in cell viability), or the cells can activate

408-492: The Cooperative Group program to modernize the existing system to support precision medicine clinical trials. With precision medicine, many patients must be screened to determine eligibility for treatments in development. Lead Academic Participating Sites (LAPS) were chosen at 30 academic institutions for their ability to conduct clinical trials and screen a large number of participants and awarded grants to support

432-410: The NCI illustrates the changes in screening that have resulted from advances in cancer biology. The Developmental Therapeutics Program (DTP) operates a tiered anti-cancer compound screening program with the goal of identifying novel chemical leads and biological mechanisms. The DTP screen is a three phase screen which includes: an initial screen which first involves a single dose cytotoxicity screen with

456-466: The cell membrane, and can only be measured in culture media after cells have lost their membrane integrity. Cytotoxicity can also be monitored using 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide ( MTT ) or with 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT), which yields a water-soluble product, or the MTS assay. This assay measures the reducing potential of

480-458: The cell using a colorimetric reaction. Viable cells will reduce the MTS reagent to a colored formazan product. A similar redox-based assay has also been developed using the fluorescent dye, resazurin . In addition to using dyes to indicate the redox potential of cells in order to monitor their viability, researchers have developed assays that use ATP content as a marker of viability. Such ATP-based assays include bioluminescent assays in which ATP

504-635: The discovery and development of new cancer therapeutic agents. Under the label "Discovery & Development Services" several services are offered, among them the NCI-60 human cancer cell line screen and the Molecular Target Program. In the Molecular Target Program thousands of molecular targets have been measured in the NCI panel of 60 human tumor cell lines. Measurements include protein levels, RNA measurements, mutation status and enzyme activity levels. The evolution of strategies at

SECTION 20

#1732780309639

528-418: The form of P30 Cancer Center Support Grants to support shared research resources and interdisciplinary programs. Additionally, faculty at the cancer centers receive approximately 75% of the grant funding awarded by the NCI to individual investigators. The NCI cancer centers program was introduced in 1971 with 15 participating institutions. The National Clinical Trials Network (NCTN) was formed in 2014, from

552-409: The infrastructure and administration required for clinical trials. Most LAPS grant recipients are also NCI-designated cancer centers. NCTN also stores surgical tissue from patients in a nationwide network of tissue banks at various universities. The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate

576-420: The inside of healthy cells; however, if the cell membrane has been compromised, they freely cross the membrane and stain intracellular components. Alternatively, membrane integrity can be assessed by monitoring the passage of substances that are normally sequestered inside cells to the outside. One molecule, lactate dehydrogenase (LDH), is commonly measured using LDH assay . LDH reduces NAD to NADH which elicits

#638361